1. Home
  2. SLBT vs ULCC Comparison

SLBT vs ULCC Comparison

Compare SLBT & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SL Science Holding Limited Ordinary Shares

SLBT

SL Science Holding Limited Ordinary Shares

N/A

Current Price

$1.66

Market Cap

942.1M

Sector

N/A

ML Signal

N/A

Logo Frontier Group Holdings Inc.

ULCC

Frontier Group Holdings Inc.

N/A

Current Price

$5.99

Market Cap

1.1B

ML Signal

N/A

Company Overview

Basic Information
Metric
SLBT
ULCC
Founded
N/A
1994
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
942.1M
1.1B
IPO Year
2025
2017

Fundamental Metrics

Financial Performance
Metric
SLBT
ULCC
Price
$1.66
$5.99
Analyst Decision
Hold
Analyst Count
0
12
Target Price
N/A
★ $6.56
AVG Volume (30 Days)
108.5K
★ 2.1M
Earning Date
N/A
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $3,724,000,000.00
Revenue This Year
N/A
$29.80
Revenue Next Year
N/A
$9.89
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.42
$3.02
52 Week High
$6.25
$8.41

Technical Indicators

Market Signals
Indicator
SLBT
ULCC
Relative Strength Index (RSI) 35.86 50.69
Support Level N/A $5.42
Resistance Level $3.36 $6.31
Average True Range (ATR) 0.18 0.27
MACD 0.02 0.05
Stochastic Oscillator 32.89 59.38

Price Performance

Historical Comparison
SLBT
ULCC

About SLBT SL Science Holding Limited Ordinary Shares

SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.

About ULCC Frontier Group Holdings Inc.

Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos, and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. The majority of revenue is from Domestic flight follow by International.

Share on Social Networks: